AzTrials
AzTrials

Obesity-hypoventilation SyndromeNCT04474587

Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV

An observational study of Obesity-hypoventilation Syndrome and Resting Energy Expenditure, run by University Hospital, Geneva at 1 site in Switzerland.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

This study aims to compare, in subjects with obesity-hypoventilation syndrome (OHS) treated by long-term non-invasive ventilation (NIV), resting energy expenditure (REE) in spontaneous breathing and under NIV. The hypothesise of this study is that REE will be lower under NIV than under spontaneous breathing. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Indirect calorimetry
How many people
30 participants
Where
1 siteSwitzerland
Study dates
1 Sep 2020to 1 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Adult, Older adult

Study population: Patients with obesity hypoventilation syndrome (OHS) trated with non-invasive ventilation (NIV).

Who may be able to join

  • Fulfill all criteria of obesity hypoventilation syndrome.
  • Under home NIV for at least 3 months.
  • Are compliant to their treatment of NIV (defined as a daily median use > 3:30 hours).
  • Have a satisfactory response to NIV (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
  • Are in a stable clinical condition (i.e. no episode of acute cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months).
  • Are over 18 years of age.
  • Are able to provide informed consent.
  • Agree to participate in the study.

Who cannot join

  • Presents any respiratory disorder other than OHS.
  • Has been under NIV less than 3 months.
  • Is noncompliant (defined above) and/or intolerant to NIV.
  • NIV not reaching the above-mentioned physiological targets (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
  • Had a recent episode of cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months.
  • Is under 18 years of age.
Show all 9Show fewer
  • Presents a situation interfering with understanding of the protocol and ability to provide informed written consent (language barrier, cognitive disorder, psychiatric disturbance).
  • Refuses to participate in the study.
  • Is under nocturnal oxygen supplementation on NIV.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Geneva University Hospital

    Geneva, 1205

Other trials in Switzerland

About this study

Official title: Impact of Noninvasive Ventilation on Resting Energy Expenditure in Patients With Obesity Hypoventilation Syndrome Treated by Long-term Home Noninvasive Ventilation.

This study aims to compare, in subjects with obesity-hypoventilation syndrome (OHS) treated by long-term non-invasive ventilation (NIV), resting energy expenditure (REE) in spontaneous breathing and under NIV. The hypothesise of this study is that REE will be lower under NIV than under spontaneous breathing.

Read the detailed description

This is an observational monocentric study in which each subject will be its own control. Patients' resting energy expenditure will be measured at rest ("spontaneous breathing" condition) and under its usual treatment ("under NIV" condition) in a cross-over fashion. Conditions measurement order will be randomly generated by a computer algorithm such that half of the patients will be measured under spontaneous breathing before under NIV and the other half of the patients will be measured under NIV before under spontaneous breathing. Resting energy expenditure will be monitored during a short-term elective hospitalization (24 hours). Albeit for measurements of REE, tests which will be performed are part of the regular follow-up of patients under long term NIV.

Primary objective is to compare in OHS patients the REE under spontaneous breathing and under NIV, using their usual settings.

Description of the intended procedures and stages:

  1. Recruitment and screening of patients fulfilling inclusion criteria will be done among patients with OHS under long-term NIV followed by our center (duration: 14 days).
  2. Once informed written consent has been provided, patients will be included in the study protocol (time provided for decision: 28 days).
  3. Patients are admitted for one night with overnight recording of nocturnal oximetry and transcutaneous capnography using their noninvasive ventilation at usual settings, prior to measurements of resting energy expenditure. Downloading of memorized data by ventilator software will also take place and will cover the previous month and the night of the study (duration: 12 hours). These procedures are part of the routine evaluation of patients under long term NIV.
  4. Body weight will be measured, as well as body composition by bioelectrical impedance: briefly, a very low intensity electric current is sent between 2 electrodes placed on the dorsum of the foot and the ipsilateral hand. Measurement of resistance and reactance allows estimation of body compartments (fat-free mass and fat mass) (duration: 30 minutes).
  5. Patients will undergo their first indirect calorimetric measurement. Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either performed with or without noninvasive ventilation (conditions order will be randomized by a computer)(duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
  6. Interval between measurements of at least 1 hour, to avoid impact of noninvasive ventilation on measurements. Between tests, they will perform pulmonary function tests and have their arterialized capillary blood gases sampled at earlobe (duration: 1 hour). These tests are part of the routine evaluation of patients under long term NIV.
  7. Patients will undergo their second indirect calorimetric measurement (see details in section on indirect calorimetric). Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either done with or without noninvasive ventilation (randomized order by a software) (duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
  8. These two tests will be performed in a randomized order (spontaneous breathing or noninvasive ventilation).
  9. Information to the patient of the results, which will also be forwarded to physician and nutritionist in charge.

In 2016-2017, seventy-four OHS patients treated at home by long-term NIV were identified in our area. Expecting a participation rate of around 50%, at least 30 patients will be included in the present study. With such a sample size, the study will have a power of 80% to detect an effect size of 0.5.

Being tested
Indirect calorimetry
Medical subject headings
Obesity Hypoventilation Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect calorimetryOther

    Measurements of REE by indirect calorimetry

Study groups in NCT04474587
Study groupRoleWhat they receive
OHS-NIVPatients with obesity-hypoventilation syndrome (OHS) treated with non-invasive ventilation (NIV).
Receives: Other: Indirect calorimetry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. REE

    Resting energy expenditure (REE) and will be determined under spontaneous breathing and under NIV with an indirect calorimetry

    Measured: Each procedure (indirect calorimetry) will take 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2020
  2. Study start1 Sep 2020
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion1 Dec 2022 (estimated)

Why it stopped: COVID pandemic

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04474587
Sponsor's protocol ID
2020-01223
Status last verified
Oct 2021
First submitted
13 Jul 2020
Last updated
8 Nov 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity-hypoventilation Syndrome and Resting Energy Expenditure, run by University Hospital, Geneva at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 8 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

REE (time frame: Each procedure (indirect calorimetry) will take 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in